Two regulatory data changes have been coming for years: ISO IDMP, the standard for identifying medicinal products, and eCTD version 4.0, the next version of the electronic submission format. Both are now real, both are being phased in, and both expose the same weakness in most companies: product information scattered across systems that do not agree with each other.
IDMP in brief
IDMP is a set of ISO standards for describing medicinal products in a consistent, structured way: substances, products, packaging, organisations and more. In Europe, EMA is implementing it through its SPOR services, which hold master data on substances, products, organisations and referentials.
The goal is that every regulator, and eventually every system in the supply chain, describes the same product the same way. For a company, it means submitting product data in a structured form, and keeping it accurate.
eCTD 4.0 in brief
eCTD 4.0 changes how submissions are built and exchanged. The main practical difference is that documents can be reused across submissions and lifecycle operations are more flexible. Regulators are introducing it in stages, with acceptance optional at first in several regions before it becomes the expected format.
For most companies the publishing tool vendor carries much of the technical change. The harder part is upstream: having consistent, controlled content and metadata to feed it.
The common weakness
Both changes depend on good product master data. Ask a simple question, such as which manufacturing sites are registered for this product in each market, and in many companies you will get different answers from regulatory, quality and supply chain. Each answer is right according to its own system.
IDMP makes that inconsistency visible to the regulator. eCTD 4.0 makes reuse more powerful, which also means reusing an error more efficiently.
A practical readiness check
- Is there one agreed source for product, substance and site data, and do other systems follow it?
- Who owns each data element, and who approves changes?
- Does change control update regulatory data, or does it rely on someone remembering?
- Can you produce a reliable list of what is registered where, without a week of manual reconciliation?
If the answers are uncertain, that is the work, and it is worth doing before any submission deadline forces it.
Do not treat it as an IT project
IDMP and eCTD 4.0 are often handed to IT or to the publishing vendor, because they look like format changes. The format is the easy part. The real work is agreeing definitions, cleaning existing data, assigning owners, and changing processes so that data stays right after the first submission.
That work needs regulatory, quality, supply chain and manufacturing in the same room. Projects that start there tend to finish. Projects that start with a system selection tend to discover the data problem halfway through.
Where we fit
Our RIM implementation work covers regulatory information management and the data governance behind it. Our RIM comparison looks at the platforms. If you want an independent readiness assessment, get in touch.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.